IL113044A0 - N-substituted beta-aryl- and beta-heteroaryl -alpha cyanoarylamide derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

N-substituted beta-aryl- and beta-heteroaryl -alpha cyanoarylamide derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL113044A0
IL113044A0 IL11304495A IL11304495A IL113044A0 IL 113044 A0 IL113044 A0 IL 113044A0 IL 11304495 A IL11304495 A IL 11304495A IL 11304495 A IL11304495 A IL 11304495A IL 113044 A0 IL113044 A0 IL 113044A0
Authority
IL
Israel
Prior art keywords
beta
alkyl
pct
hydrogen
cyanoarylamide
Prior art date
Application number
IL11304495A
Other languages
English (en)
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of IL113044A0 publication Critical patent/IL113044A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11304495A 1994-03-28 1995-03-20 N-substituted beta-aryl- and beta-heteroaryl -alpha cyanoarylamide derivatives, their preparation and pharmaceutical compositions containing them IL113044A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9406137A GB9406137D0 (en) 1994-03-28 1994-03-28 N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
IL113044A0 true IL113044A0 (en) 1995-06-29

Family

ID=10752648

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11304495A IL113044A0 (en) 1994-03-28 1995-03-20 N-substituted beta-aryl- and beta-heteroaryl -alpha cyanoarylamide derivatives, their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US5652250A (xx)
EP (1) EP0700388B1 (xx)
JP (1) JPH08511562A (xx)
KR (1) KR960702442A (xx)
CN (1) CN1125942A (xx)
AT (1) ATE224371T1 (xx)
AU (1) AU685599B2 (xx)
DE (1) DE69528229T2 (xx)
ES (1) ES2183866T3 (xx)
FI (1) FI955661A (xx)
GB (1) GB9406137D0 (xx)
HU (1) HUT73811A (xx)
IL (1) IL113044A0 (xx)
MX (1) MX9504895A (xx)
MY (1) MY130160A (xx)
NO (1) NO954692L (xx)
NZ (1) NZ281630A (xx)
PL (1) PL311745A1 (xx)
TW (1) TW347386B (xx)
WO (1) WO1995026341A1 (xx)
ZA (1) ZA952423B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613021D0 (en) * 1996-06-21 1996-08-28 Pharmacia Spa Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
WO1997049653A2 (en) * 1996-06-24 1997-12-31 Irori Solid phase tyrphostin library linked to matrices with memories
JP2002504529A (ja) 1998-02-27 2002-02-12 ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 二置換ラベンダスティンａ類似体およびこれらの類似体を含む薬学的組成物
HUP0000920A3 (en) * 2000-02-28 2002-03-28 Sanofi Synthelabo Pde4 inhibitor isoquinolinylidene derivatives, process for their preparation and medicaments containing them
CA2406160A1 (en) * 2000-04-13 2001-10-25 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
EP1752446A3 (en) * 2000-04-13 2007-03-21 HSC Research and Development Limited Partnership Compounds for modulating cell proliferation
CA2463133A1 (en) * 2001-10-11 2003-04-17 The Hospital For Sick Children Styryl acrylonitrile compounds and their use to promote myelopoiesis
EP1701941B1 (en) * 2003-12-11 2012-05-30 Board of Regents, The University of Texas System Compounds for treatment of cell proliferative diseases
JP2007530455A (ja) 2004-03-26 2007-11-01 エイチエスシー リサーチ アンド ディベロップメント リミテッド パートナーシップ 細胞増殖を調節する化合物
US20100292229A1 (en) * 2006-06-30 2010-11-18 The Board Of Regents Of The University Of Texas System Tryphostin-analogs for the treatment of cell proliferative diseases
PL2307367T3 (pl) 2008-07-08 2015-03-31 Univ Texas Nowe inhibitory proliferacji i aktywacji białek przekazujących sygnał i aktywujących transkrypcję (STAT)
WO2011060440A2 (en) * 2009-11-16 2011-05-19 The Regents Of The University Of California Kinase inhibitors
CN103459371A (zh) * 2011-04-02 2013-12-18 中国人民解放军军事医学科学院毒物药物研究所 芳基丙烯酰胺化合物及其用于制备免疫抑制剂的用途
WO2012158843A2 (en) * 2011-05-17 2012-11-22 The Regents Of The University Of California Kinase inhibitors
CA2860022A1 (fr) * 2011-12-30 2013-07-04 Universite D'auvergne Clermont I Composes anti-douleur
CN105705504A (zh) * 2013-10-10 2016-06-22 密歇根大学董事会 去泛素化酶抑制剂及其使用方法
CN108276366B (zh) * 2018-01-08 2021-09-03 四川大学 一种丙烯酰胺类衍生物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000950D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa New arylvinylamide derivatives and process for their preparation
GB9000939D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa Improvement in the total synthesis of erbstatin analogs
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
CA2080582A1 (en) * 1990-04-16 1991-10-17 Alfred P. Spada Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
GB9115160D0 (en) * 1991-07-12 1991-08-28 Erba Carlo Spa Methylen-oxindole derivatives and process for their preparation
CA2080554A1 (en) * 1991-10-15 1993-04-16 Mitsubishi Chemical Corporation Styrene derivatives
GB9204945D0 (en) * 1992-03-06 1992-04-22 Erba Carlo Spa 3-aryl-glycidic ester derivatives and process for their preparation
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation

Also Published As

Publication number Publication date
WO1995026341A1 (en) 1995-10-05
HUT73811A (en) 1996-09-30
US5652250A (en) 1997-07-29
JPH08511562A (ja) 1996-12-03
KR960702442A (ko) 1996-04-27
ZA952423B (en) 1995-12-19
FI955661A0 (fi) 1995-11-24
EP0700388B1 (en) 2002-09-18
DE69528229T2 (de) 2003-08-14
GB9406137D0 (en) 1994-05-18
NZ281630A (en) 1998-02-26
TW347386B (en) 1998-12-11
DE69528229D1 (en) 2002-10-24
MY130160A (en) 2007-06-29
AU685599B2 (en) 1998-01-22
PL311745A1 (en) 1996-03-18
CN1125942A (zh) 1996-07-03
NO954692D0 (no) 1995-11-20
HU9503714D0 (en) 1996-02-28
NO954692L (no) 1995-11-20
EP0700388A1 (en) 1996-03-13
ES2183866T3 (es) 2003-04-01
FI955661A (fi) 1996-01-19
AU1849895A (en) 1995-10-17
MX9504895A (es) 1998-03-31
ATE224371T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
IL113044A0 (en) N-substituted beta-aryl- and beta-heteroaryl -alpha cyanoarylamide derivatives, their preparation and pharmaceutical compositions containing them
IL112010A0 (en) Pharmaceutical compositions comprising 3-substituted oxindol derivatives having anti-angiogenic avtivity
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
ES8705837A1 (es) Un procedimiento para la preparacion de derivados de naftaleno.
MX9504349A (es) Derivados de aroilpiperidina.
IL102383A0 (en) Methylene-oxindole derivatives,their preparation and pharmaceutical compositions containing them
IL111127A (en) Short-acting calcium antagonist dihydropyridines process for their preparation and pharmaceutical compositions containing them
YU4795A (sh) Derivati indola koji se mogu koristiti kao 5ht agonisti, farmaceutski preparati koji ih sadrže i postupci njihovog dobijanja
IL104567A0 (en) Ethanolamine derivatives,processes for the preparation thereof and a pharmaceutical composition containing the same
PT674621E (pt) Enantiomeros de derivados de carbazolo como agonistas do tipo 5-ht
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
YU78100A (sh) 4,5,6 i 7-indol i indolin derivati, njihova izrada i upotreba
CA2163115A1 (en) N-substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
IL148590A0 (en) Alkaloid compounds and pharmaceutical compositions containing the same
HUT75343A (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing the said compds.
ES8207519A1 (es) Procedimiento para la obtencion de derivados del imidazol.
DE3370322D1 (en) 1,1-diphenylpropanol derivatives, process for their preparation and pharmaceutical compositions containing them